226 related articles for article (PubMed ID: 34764812)
1. Pancreatic cancer and adaptive metabolism in a nutrient-deficient environment.
Słotwiński R; Słotwińska SM
Cent Eur J Immunol; 2021; 46(3):388-394. PubMed ID: 34764812
[TBL] [Abstract][Full Text] [Related]
2. Molecular aspects of pancreatic cancer: focus on reprogrammed metabolism in a nutrient-deficient environment and potential therapeutic targets.
Słotwiński R; Lech G; Słotwińska SM
Cent Eur J Immunol; 2021; 46(2):258-263. PubMed ID: 34764796
[TBL] [Abstract][Full Text] [Related]
3. Autophagy Contributes to Metabolic Reprogramming and Therapeutic Resistance in Pancreatic Tumors.
Reyes-Castellanos G; Abdel Hadi N; Carrier A
Cells; 2022 Jan; 11(3):. PubMed ID: 35159234
[TBL] [Abstract][Full Text] [Related]
4. Metabolic reprogramming by driver mutation-tumor microenvironment interplay in pancreatic cancer: new therapeutic targets.
Andersen HB; Ialchina R; Pedersen SF; Czaplinska D
Cancer Metastasis Rev; 2021 Dec; 40(4):1093-1114. PubMed ID: 34855109
[TBL] [Abstract][Full Text] [Related]
5. UBL4A inhibits autophagy-mediated proliferation and metastasis of pancreatic ductal adenocarcinoma via targeting LAMP1.
Chen H; Li L; Hu J; Zhao Z; Ji L; Cheng C; Zhang G; Zhang T; Li Y; Chen H; Pan S; Sun B
J Exp Clin Cancer Res; 2019 Jul; 38(1):297. PubMed ID: 31288830
[TBL] [Abstract][Full Text] [Related]
6. Harnessing metabolic dependencies in pancreatic cancers.
Encarnación-Rosado J; Kimmelman AC
Nat Rev Gastroenterol Hepatol; 2021 Jul; 18(7):482-492. PubMed ID: 33742165
[TBL] [Abstract][Full Text] [Related]
7. Glucose Metabolism in Pancreatic Cancer.
Yan L; Raj P; Yao W; Ying H
Cancers (Basel); 2019 Sep; 11(10):. PubMed ID: 31569510
[TBL] [Abstract][Full Text] [Related]
8. A low amino acid environment promotes cell macropinocytosis through the YY1-FGD6 axis in Ras-mutant pancreatic ductal adenocarcinoma.
Zhang YF; Li Q; Huang PQ; Su T; Jiang SH; Hu LP; Zhang XL; Sun Y; Pan H; Yang XM; Li J; Gai YZ; Zhu L; Yao LL; Li DX; Sun YW; Zhang ZG; Liu DJ; Zhang YL; Nie HZ
Oncogene; 2022 Feb; 41(8):1203-1215. PubMed ID: 35082383
[TBL] [Abstract][Full Text] [Related]
9. Targets (Metabolic Mediators) of Therapeutic Importance in Pancreatic Ductal Adenocarcinoma.
Rai V; Agrawal S
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33198082
[TBL] [Abstract][Full Text] [Related]
10. Targeting the Metabolic Rewiring in Pancreatic Cancer and Its Tumor Microenvironment.
Yamamoto K; Iwadate D; Kato H; Nakai Y; Tateishi K; Fujishiro M
Cancers (Basel); 2022 Sep; 14(18):. PubMed ID: 36139512
[TBL] [Abstract][Full Text] [Related]
11. Macropinocytosis: the big drinker behind cancer cell self-consumption.
Su H; Yang F; Sun B; Karin M
Autophagy; 2021 May; 17(5):1290-1291. PubMed ID: 33879021
[TBL] [Abstract][Full Text] [Related]
12. Reprogramming of Amino Acid Metabolism in Pancreatic Cancer: Recent Advances and Therapeutic Strategies.
Xu R; Yang J; Ren B; Wang H; Yang G; Chen Y; You L; Zhao Y
Front Oncol; 2020; 10():572722. PubMed ID: 33117704
[TBL] [Abstract][Full Text] [Related]
13. The plasticity of pancreatic cancer metabolism in tumor progression and therapeutic resistance.
Biancur DE; Kimmelman AC
Biochim Biophys Acta Rev Cancer; 2018 Aug; 1870(1):67-75. PubMed ID: 29702208
[TBL] [Abstract][Full Text] [Related]
14. Molecular Pathways Controlling Autophagy in Pancreatic Cancer.
New M; Van Acker T; Long JS; Sakamaki JI; Ryan KM; Tooze SA
Front Oncol; 2017; 7():28. PubMed ID: 28316954
[TBL] [Abstract][Full Text] [Related]
15. Tumor microenvironment interactions with cancer stem cells in pancreatic ductal adenocarcinoma.
Palma AM; Bushnell GG; Wicha MS; Gogna R
Adv Cancer Res; 2023; 159():343-372. PubMed ID: 37268400
[TBL] [Abstract][Full Text] [Related]
16. Roles of autophagy and metabolism in pancreatic cancer cell adaptation to environmental challenges.
Maertin S; Elperin JM; Lotshaw E; Sendler M; Speakman SD; Takakura K; Reicher BM; Mareninova OA; Grippo PJ; Mayerle J; Lerch MM; Gukovskaya AS
Am J Physiol Gastrointest Liver Physiol; 2017 Nov; 313(5):G524-G536. PubMed ID: 28705806
[TBL] [Abstract][Full Text] [Related]
17. Myoferlin controls mitochondrial structure and activity in pancreatic ductal adenocarcinoma, and affects tumor aggressiveness.
Rademaker G; Hennequière V; Brohée L; Nokin MJ; Lovinfosse P; Durieux F; Gofflot S; Bellier J; Costanza B; Herfs M; Peiffer R; Bettendorff L; Deroanne C; Thiry M; Delvenne P; Hustinx R; Bellahcène A; Castronovo V; Peulen O
Oncogene; 2018 Aug; 37(32):4398-4412. PubMed ID: 29720728
[TBL] [Abstract][Full Text] [Related]
18. Identification of distinct slow mode of reversible adaptation of pancreatic ductal adenocarcinoma to the prolonged acidic pH microenvironment.
Wu TC; Liao CY; Lu WC; Chang CR; Tsai FY; Jiang SS; Chen TH; Lin KM; Chen LT; Chang WW
J Exp Clin Cancer Res; 2022 Apr; 41(1):137. PubMed ID: 35410237
[TBL] [Abstract][Full Text] [Related]
19. Macropinocytosis in Cancer-Associated Fibroblasts Is Dependent on CaMKK2/ARHGEF2 Signaling and Functions to Support Tumor and Stromal Cell Fitness.
Zhang Y; Recouvreux MV; Jung M; Galenkamp KMO; Li Y; Zagnitko O; Scott DA; Lowy AM; Commisso C
Cancer Discov; 2021 Jul; 11(7):1808-1825. PubMed ID: 33653692
[TBL] [Abstract][Full Text] [Related]
20. Autophagy supports mitochondrial metabolism through the regulation of iron homeostasis in pancreatic cancer.
Mukhopadhyay S; Encarnación-Rosado J; Lin EY; Sohn ASW; Zhang H; Mancias JD; Kimmelman AC
Sci Adv; 2023 Apr; 9(16):eadf9284. PubMed ID: 37075122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
